{"@context":"https:\/\/schema.org","@type":"BreadcrumbList","itemListElement":[{"@type":"ListItem","position":1,"name":"An Open-label, Phase 1b Study of study drug in Patients with Lower-risk Myelodysplastic Syndromes (LR MDS) Who are Refractory\/Resistant to Prior Therapies","item":"https:\/\/www.regionalcancercare.org\/trials\/an-open-label-phase-1b-study-of-study-drug-in-patients-with-lower-risk-myelodysplastic-syndromes-lr-mds-who-are-refractory-resistant-to-prior-therapies\/#breadcrumbitem"}]}